[Transplantability, development and methotrexate sensitivity of mouse leukemia L1210 resistant to olivomycin].
A total of 52-fold passages of leukemia L-1210 were carried out for a year on mice treated intraperitoneally with olivomycin. Prolonged exposure to olivomycin resulted in decreased transplantability of the tumor cells. The tumor cells obtained under the effect of olivomycin were more sensitive (collateral sensitivity) to methotrexate as compared to the cells of the initial strain L-1210. An intramuscular route for transplantation of the tumor cells of leukemia L-1210 is recommended. The dosage intramuscular transplantation of the tumor cells provided simultaneously data on transplantability, tumor size and lifer-time of mice.
D000818:Animals; D004351:Drug Resistance; D007114:Immunization; D007939:Leukemia L1210 / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D051379:Mice; D008811:Mice, Inbred DBA; D009368:Neoplasm Transplantation; D009848:Olivomycins / Q000037:antagonists & inhibitors*; D013997:Time Factors
D009848:Olivomycins; D008727:Methotrexate
Privivaemost', razvitie i chuvstvitel'nost' k metotreksatu leĭkoza mysheĭ L-1210, ustoĭchivogo k olivomitsinu.